Testing a new drug for healthy adults and those with diabetic kidney disease
Part of Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new medication called MTX-439. It includes healthy adults and people with diabetic kidney disease to see if the drug is safe and to learn how the body handles it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have diabetic kidney disease with well-controlled diabetes, or you are a healthy adult.
- You do not smoke or use nicotine products more than 5 times per week, and you agree not to use them during stays.
- You are willing to avoid marijuana and related products for 30 days before and during the study.
- You agree to use birth control as required and to not donate eggs or sperm for a specific time.
- You have no major medical conditions like cancer, infections (hepatitis B, C, or HIV), or severe depression in the past 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug, R3R01, can help reduce protein leaking into the urine in people with diabetic kidney disease. It may offer a new option for managing kidney health.
This study tests a new medicine called AP303 for people with type 2 diabetes and chronic kidney disease. The goal is to see if it is safe and how the body processes it. If you have diabetes and your kidneys are not working as well as they used to, this trial might help find new treatment options.
This trial tests a new drug called MTX-101 in healthy volunteers to see if it is safe and how the body processes it. It helps determine the right dose before testing in patients with certain conditions.
This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.
This trial tests a new medicine called MT-201 to see if it is safe and how the body handles it. It is for healthy volunteers aged 19 to 55 who are willing to follow study rules.
This study tests a new drug called IGT-303 for people with chronic kidney disease caused by type 2 diabetes. It aims to see if the drug is safe and can help protect kidney function.
Hear when a new Diabetic Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.